Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Kevin DeJong
ID:
1b83dfec-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
21 articles
Regeneron Identifies Six Patents for Expedited Trial in BPCIA Aflibercept Case Against Mylan
Big Molecule Watch ·
October 31, 2022
cite
Expedited Trial Ordered in Regeneron Aflibercept BPCIA Case Against Mylan
Big Molecule Watch ·
October 28, 2022
cite
Celltrion’s Bevacizumab Biosimilar Approved by FDA
Big Molecule Watch ·
September 30, 2022
cite
Regeneron Seeks Expedited Trial in BPCIA Case Against Mylan Regarding Aflibercept Biosimilar
Big Molecule Watch ·
September 13, 2022
cite
Biogen Files Sealed Complaint Against Sandoz and Polpharma Biologics Regarding Natalizumab
Big Molecule Watch ·
September 12, 2022
cite
Previous
1
2
3
4
5
Next
